JPS6355670B2 - - Google Patents
Info
- Publication number
- JPS6355670B2 JPS6355670B2 JP56134232A JP13423281A JPS6355670B2 JP S6355670 B2 JPS6355670 B2 JP S6355670B2 JP 56134232 A JP56134232 A JP 56134232A JP 13423281 A JP13423281 A JP 13423281A JP S6355670 B2 JPS6355670 B2 JP S6355670B2
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- alkyl group
- blood
- tube
- branched alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000926 separation method Methods 0.000 claims description 118
- 239000008280 blood Substances 0.000 claims description 92
- 210000004369 blood Anatomy 0.000 claims description 91
- 239000003795 chemical substances by application Substances 0.000 claims description 71
- 125000004432 carbon atom Chemical group C* 0.000 claims description 60
- 229920001577 copolymer Polymers 0.000 claims description 50
- 125000000217 alkyl group Chemical group 0.000 claims description 48
- 230000005484 gravity Effects 0.000 claims description 45
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 38
- 210000002966 serum Anatomy 0.000 claims description 36
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 33
- 239000011976 maleic acid Substances 0.000 claims description 33
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 33
- 239000004711 α-olefin Substances 0.000 claims description 33
- 230000023555 blood coagulation Effects 0.000 claims description 25
- 208000007536 Thrombosis Diseases 0.000 claims description 20
- -1 2-ethylhexyl group Chemical group 0.000 claims description 17
- 229910021647 smectite Inorganic materials 0.000 claims description 17
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 16
- 239000004927 clay Substances 0.000 claims description 14
- 239000000377 silicon dioxide Substances 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 11
- 230000009974 thixotropic effect Effects 0.000 claims description 11
- 210000000601 blood cell Anatomy 0.000 claims description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- 239000003349 gelling agent Substances 0.000 claims description 9
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims description 8
- 239000003607 modifier Substances 0.000 claims description 8
- 239000004745 nonwoven fabric Substances 0.000 claims description 8
- 230000001737 promoting effect Effects 0.000 claims description 8
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 239000005909 Kieselgur Substances 0.000 claims description 5
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 5
- 150000001336 alkenes Chemical class 0.000 claims description 4
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 4
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000005995 Aluminium silicate Substances 0.000 claims description 2
- 229920000742 Cotton Polymers 0.000 claims description 2
- 235000012211 aluminium silicate Nutrition 0.000 claims description 2
- 239000000440 bentonite Substances 0.000 claims description 2
- 229910000278 bentonite Inorganic materials 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 2
- 239000000126 substance Substances 0.000 description 26
- 239000000463 material Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- 238000005119 centrifugation Methods 0.000 description 13
- 206010018910 Haemolysis Diseases 0.000 description 9
- 230000008588 hemolysis Effects 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000011230 binding agent Substances 0.000 description 7
- 238000005191 phase separation Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000005871 repellent Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 230000015271 coagulation Effects 0.000 description 4
- 238000005345 coagulation Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 102000009123 Fibrin Human genes 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- 238000005243 fluidization Methods 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 230000002940 repellent Effects 0.000 description 3
- 238000010008 shearing Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 125000001931 aliphatic group Chemical class 0.000 description 2
- 238000010876 biochemical test Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004388 gamma ray sterilization Methods 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229910002016 Aerosil® 200 Inorganic materials 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 229910002026 crystalline silica Inorganic materials 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 239000012052 hydrophilic carrier Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/491—Blood by separating the blood components
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Ecology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56134232A JPS5835463A (ja) | 1981-08-28 | 1981-08-28 | 血液分離管 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56134232A JPS5835463A (ja) | 1981-08-28 | 1981-08-28 | 血液分離管 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5835463A JPS5835463A (ja) | 1983-03-02 |
| JPS6355670B2 true JPS6355670B2 (enrdf_load_stackoverflow) | 1988-11-04 |
Family
ID=15123509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56134232A Granted JPS5835463A (ja) | 1981-08-28 | 1981-08-28 | 血液分離管 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5835463A (enrdf_load_stackoverflow) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58206964A (ja) * | 1982-05-28 | 1983-12-02 | Terumo Corp | 血液分離管 |
| JPH0677014B2 (ja) * | 1987-08-14 | 1994-09-28 | テルモ株式会社 | 血液分離管 |
| CA2004535A1 (en) * | 1988-12-08 | 1990-06-08 | Toru Tagawa | Liquid separating agent |
| ATE423312T1 (de) | 2001-12-04 | 2009-03-15 | Sekisui Chemical Co Ltd | Zusammensetzung zur trennung von blutserum oder - plasma und diese enthaltendes gefäss zur blutuntersuchung |
| CN109266531A (zh) * | 2018-10-08 | 2019-01-25 | 陈琼娣 | 一种外周血单个核细胞分离管及其制备方法 |
-
1981
- 1981-08-28 JP JP56134232A patent/JPS5835463A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5835463A (ja) | 1983-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4770779A (en) | Apparatus for separating blood | |
| EP0035575B1 (en) | Blood serum-separating agent | |
| US4257886A (en) | Apparatus for the separation of blood components | |
| JP5297191B2 (ja) | 血清または血漿分離用組成物及び血液検査用容器 | |
| US4946601A (en) | Blood serum separator tube | |
| US4049692A (en) | Stabilized blood separating composition | |
| JPS6348310B2 (enrdf_load_stackoverflow) | ||
| JPS6355670B2 (enrdf_load_stackoverflow) | ||
| CN100413506C (zh) | 改进的药物组合物 | |
| BRPI0616455A2 (pt) | composição farmacêutica estabilizada em partìculas vìtreas, e dispositivos de injeção, agulha e seringa ulitilizando a mesma | |
| JP2021531059A (ja) | 血液を処理するための装置および方法 | |
| JP2582191B2 (ja) | ゲル状材料 | |
| JPH02168159A (ja) | 血液分離剤 | |
| IE50322B1 (en) | Serum-separating agent | |
| JPH0142382B2 (enrdf_load_stackoverflow) | ||
| GB2132759A (en) | Blood collecting tube | |
| JPS58208341A (ja) | ポリイソブチレンエマルジヨン | |
| KR100598871B1 (ko) | 유성 요변성 제제 | |
| JPS58206964A (ja) | 血液分離管 | |
| JPH0513270B2 (enrdf_load_stackoverflow) | ||
| JPH06100595B2 (ja) | 液体分離剤 | |
| BE885169A (fr) | Agent de fractionnement de liquide | |
| HU205909B (en) | Process for improving fluidity of fine-grain, dimerized 2,4-toluilene-diisocyanate and inhibiting it's agglomeration | |
| JPH0125026B2 (enrdf_load_stackoverflow) | ||
| JPS596655B2 (ja) | 血清分離用採血管 |